What is the global market size of Small Animal Imaging Market?

Small Animal Imaging Market size was valued at USD 8.83 billion in 2022 and is poised to grow from USD 9.39 billion in 2023 to USD 15.45 billion by 2031, growing at a CAGR of 6.42% in the forecast period (2024-2031)

Who are the key vendors in the Global Small Animal Imaging Market?

The global small animal imaging market is a highly competitive landscape, characterized by the presence of several key players offering advanced imaging technologies and solutions. Small animal imaging involves the use of non-invasive imaging modalities to visualize and study the anatomical, functional, and molecular aspects of small animals, such as mice and rats, for research purposes. 'PerkinElmer (US)', 'Bruker Corporation (US)', 'FUJIFILM VisualSonics Inc. (Canada)', 'Mediso Ltd. (Hungary)', 'MILabs B.V. (Netherlands)', 'Aspect Imaging Ltd. (Israel)', 'MR Solutions Ltd. (United Kingdom)', 'Trifoil Imaging (US)', 'Siemens Healthineers (Germany)', 'GE Healthcare (US)', 'Agilent Technologies, Inc. (US)', 'MILabs B.V. (Netherlands)', 'SCANCO Medical AG (Switzerland)', 'Bioscan, Inc. (US)', 'LI-COR Biosciences (US)', 'Aspect Imaging Ltd. (Israel)', 'MR Solutions Ltd. (UK)', 'Scanco Medical AG (Switzerland)', 'Life Technologies Corporation (US)', 'Promega Corporation (US)'

Small Animal Imaging Market Size

Small Animal Imaging Market Insights

Small Animal Imaging Market size was valued at USD 9.39 Billion in 2023 and is poised to grow from USD 9.99 Billion in 2024 to USD 16.44 Billion by 2032, growing at a CAGR of 6.42% during the forecast period (2025-2032).

The global small animal imaging market has been experiencing significant growth in recent years. It plays a crucial role in drug discovery and development, disease research, and understanding biological processes in small animals. Small animal imaging techniques provide researchers with valuable insights into the molecular and cellular processes associated with diseases, allowing for the development of targeted therapies and personalized treatment approaches. The pharmaceutical and biotechnology industries are major contributors to the demand for small animal imaging technologies. These industries heavily rely on preclinical studies to evaluate the safety and efficacy of new drug candidates.

Additionally, technological advancements in small animal imaging systems have fueled market growth. The development of high-resolution imaging modalities, improved image quality, and faster scanning capabilities have enhanced the accuracy and efficiency of preclinical studies. Moreover, the integration of multimodal imaging techniques and the introduction of hybrid imaging systems have expanded the capabilities of small animal imaging, enabling researchers to gather more comprehensive and precise data.

FAQs

The global small animal imaging market is a highly competitive landscape, characterized by the presence of several key players offering advanced imaging technologies and solutions. Small animal imaging involves the use of non-invasive imaging modalities to visualize and study the anatomical, functional, and molecular aspects of small animals, such as mice and rats, for research purposes. 'PerkinElmer, Inc. ', 'Bruker Corporation ', 'Fujifilm Holdings Corporation ', 'Mediso Ltd. ', 'Milabs B.V. ', 'MR Solutions Ltd. ', 'Aspect Imaging Ltd. ', 'Li-Cor Biosciences ', 'Trifoil Imaging ', 'Miltenyi Biotec GmbH ', 'Thermo Fisher Scientific Inc ', 'Siemens AG ', 'Promega Corporation ', 'GE Healthcare ', 'Agilent Technologies, Inc. ', 'SCANCO Medical AG ', 'Bioscan, Inc. ', 'Life Technologies Corporation ', 'Analytik Jena GmbH+Co. Kg ', 'Heska Corporation '

The growing emphasis on preclinical research in pharmaceuticals, biotechnology, and life sciences is fueling the demand for small animal imaging systems. These advanced imaging technologies enable researchers to conduct in-depth studies on diseases, monitor disease progression, evaluate treatment effectiveness, and assess the safety and toxicity of new drugs or therapies.

One key market trend in the global small animal imaging market is the increasing adoption of multimodal imaging techniques. Multimodal imaging involves the integration of multiple imaging modalities to provide a comprehensive and in-depth understanding of biological processes and disease progression in small animals. This trend is driven by the need for more accurate and detailed imaging data in preclinical research and drug development. By combining different imaging techniques such as positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging, researchers can obtain complementary information and improve the overall sensitivity and specificity of imaging studies.

The dominant region in the global small animal imaging market is North America. North America has been at the forefront of research and development in the field of small animal imaging, with a strong presence of pharmaceutical and biotechnology companies, academic research institutions, and advanced healthcare infrastructure. The region has witnessed significant investments in preclinical research, drug discovery, and development, which have propelled the demand for small animal imaging technologies.